Arcturus Therapeutics
Price & Volume
Stats
See moreOpen | $12.42 |
Previous Close | $12.61 |
Day Range | $11.91-$12.56 |
52W Range | $5.50-$24.17 |
Market Cap | $390.5M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $29.3M |
Revenue Growth (YoY) | -89.5% |
Gross Profit (12 Mos) | -$57.4M |
Diluted EPS | -$3.33 |
News
See moreYahoo Finance • 2 days ago
Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus
Yahoo Finance • 20 days ago
Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency
Yahoo Finance • 25 days ago
Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform
Yahoo Finance • 2 months ago
Can mRNA Cure Cancer? Inside the Pipeline Risks for Biotech’s Biggest Players
About
CEO | Mr. Joseph E. Payne M.Sc. |
Address | 10285 Science Center Drive, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 106 |